The company utilises rigorous methodology to conduct scientific-standard experiments for its blue-chip client base, aiming to enhance the employee experience and drive organisational change.

Working collaboratively with its clients and leading academics from some of the world’s most prestigious universities, the company instils rigorous standards into innovation, inclusion, ethics and performance.

Operating internationally, the company caters to organisations across a broad spectrum of industries, including blue-chip organisations in the pharmaceuticals, telecommunications, and technology sectors.

The shareholder is offering the company for sale to facilitate its continued growth under the impetus of a new owner.

Offers invited.

Key Highlights

– Caters to 13 active clients, 90% of whom provide regular, repeat business, with some relationships spanning four years.

– Circa 90% of revenue generated from international clients.

– Experienced second-tier management team in place.

– Operates from co-working office space located in London.

– Main routes to growth are attracting new blue-chip clients and developing additional services through its existing lab model, with several new ventures planned for the next few months.

Financial Highlights

– Turnover of £502K, with an EBIT of £287k

– Turnover forecast to rise to £750k in YE23 and £950k in YE24.

– Pipeline currently valued at £605,200. This comprises opportunities with several new and existing clients.